CytoDyn (CYDY) Return on Capital Employed Growth (3y) (2014 - 2026)
CytoDyn (CYDY) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | 4,893.00 |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | -3,782.00 |
| 10 | CytoDyn | 255.04 Mn | 255.04 Mn | - | -135.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -135.00 |
| Nov 30, 2025 | -7,681.00 |
| Aug 31, 2025 | -10,968.00 |
| May 31, 2025 | -25,530.00 |
| Feb 28, 2025 | -54,033.00 |
| Nov 30, 2024 | -89,554.00 |
| Aug 31, 2024 | -92,240.00 |
| May 31, 2024 | -32,750.00 |
| Feb 29, 2024 | -7.10 Mn |
| Nov 30, 2023 | 354,379.00 |
| Aug 31, 2023 | -192,209.00 |
| May 31, 2023 | 4.53 Mn |
| Feb 28, 2023 | -37,496.00 |
| Nov 30, 2022 | -32,014.00 |
| Aug 31, 2022 | -145,775.00 |
| May 31, 2022 | -65,368.00 |
| Feb 28, 2022 | -235,529.00 |
| Nov 30, 2021 | 28,792.00 |
| Aug 31, 2021 | 61,559.00 |
| May 31, 2021 | -10,071.00 |